Skip to content

    Niva Bupa Health Insurance Company Limited

    NIVABUPAGood
    Financial Services·29 Jan 2026
    Management Summary

    Niva Bupa Health delivered a strong Q3 FY26, marked by accelerated growth in new business and an expanding retail market share. Profitability saw a significant YoY improvement, and the combined ratio strengthened due to better expense management, which offset a slight increase in the loss ratio. Management highlighted positive tailwinds from GST changes, strong traction for its new 'Reassure 3.0' product, and ongoing industry-wide initiatives to manage claims costs through standardization, positioning the company for sustained performance.

    Highlights

    8
    • 9-month IFRS PAT grew 74% YoY to ₹208 crores from ₹120 crores.

    • Q3 FY26 IFRS PAT stood at ₹77 crores, compared to ₹60 crores YoY.

    • Overall business grew 26% for 9M FY26, with strong retail growth of 33%.

    • Q3 FY26 growth accelerated to 31%, with new business growing 46%.

    • Retail market share for the 9-month period improved to 10%.

    • 9-month IFRS Combined Ratio improved by 50 bps to 102.9%.

    • Solvency ratio remains healthy at 2.49, with AUM around ₹9,000 crores.

    • Gross commission ratio reduced from 23% in H1 to 21% in Q3, reflecting GST pass-through.

    What Changed2

    vs Q4 FY26

    Risks discussed1 → 3 (+2)Q&A highlights8 → 3 (-5)
    Key financials

    Metrics

    6

    Periods

    3

    Headline

    2
    • Solvency Ratio
      2.49 ratio
    • AUM
      ₹9,000 Cr

    9M

    1
    • Group Loss Ratio
      62%

    9M IFRS

    3
    • PAT
      ₹208 Cr
      YoY+74%
    • Combined Ratio
      102.9%
    • Retail Loss Ratio
      66.9%

    Segment breakdown

    9M GrowthQ3 Growth
    Retail Business33%
    Group Business12%
    Agency Channel32%43%
    Banca/NBFC Channel19%27.5%
    Digital Channel49%70%
    Heatmap· 2 shared metrics

    Guidance & targets

    3
    CategoryTargetPriority
    Profitability
    Return on Equity (ROE)
    High teens
    Medium
    Other
    Common Rate Empanelled Hospitals
    5,000
    High
    Other
    EOM Compliance
    Meet regulatory requirement
    High

    Risks & concerns

    4
    RiskSeverity

    Rising Group Business Loss Ratio

    The group loss ratio increased to 62% from 57% last year. Management is mitigating this by slowing growth in this segment to 12%.Analyst acknowledged

    medium

    Uncertainty around future regulatory action on EoM/Commissions

    Management stated they have no visibility on potential future changes to distribution cost regulations, indicating an unquantifiable regulatory risk.Analyst deflected

    medium

    Accounting noise from IGAAP standards

    Management acknowledged the volatility in IGAAP reporting due to accounting rules and seasonality, strongly guiding analysts to use IFRS for a true view of performance.Analyst acknowledged

    low

    Areas of Evasion(1)

    • Future regulatory action on EoM/Commissions

    Q&A highlights

    3

    “the supernormal growth in last quarter, the earned premium of this will take time. So, the mix change we have to see not only in terms of GWP, but more like earned premium. It will reflect over a period of time. So, in that sense, if we look at our planning, our modeling, etc., this loss ratio being stable itself is, I mean, looking pretty good to us.”

    It clarifies the lag effect of new business on earned premium and loss ratios, setting realistic expectations for near-term profitability metrics.

    asked by Supratim Datta

    2 min read6 chapters

    Detailed Narrative

    01

    Robust Growth Momentum Continues, Market Share Expands to 10%

    Niva Bupa reported strong top-line performance with overall growth of 26% and retail growth of 33% for the first nine months of FY26. The momentum accelerated in Q3 with 31% overall growth and a 46% surge in new business. This performance helped the company increase its retail market share to 10% for the 9-month period, up from 9.6% in H1. Management attributed the Q3 strength partly to positive tailwinds from GST changes, which drove both volume growth (29%) and value growth via a 15% ticket size increase.

    02

    Profitability Surges with Improved Combined Ratio

    On an IFRS basis, Profit After Tax (PAT) for the nine months grew 74% YoY to ₹208 crores. The Q3 PAT stood at ₹77 crores, achieved despite a one-off📎 impact of ₹20 crores from new wage codes. The 9-month combined ratio improved by 50 basis points to 102.9%, driven by a 1.6% reduction in the expense ratio which more than offset a 1.1% increase in the loss ratio due to mix changes. The retail loss ratio remained stable at 66.9%.

    03

    Digital Channel Leads Growth; Agency Remains Strong

    The company saw broad-based growth across its distribution channels. The direct digital channel was the standout performer, growing 70% in Q3 and 49% for the nine-month period. The agency channel also demonstrated strong momentum with 43% growth in Q3 and 32% for the nine months. The bancassurance and NBFC channel grew at a more moderate 27.5% in Q3 and 19% YTD. In contrast, the group business (B2B employer-employee) grew at a much slower 12%, a deliberate strategy to focus on profitable segments.

    04

    Proactive Cost Management and Industry Collaboration Drive Efficiency

    Management highlighted successful efforts to manage acquisition costs. The gross commission ratio fell by 2 percentage points from 23% in H1 to 21% in Q3, largely due to passing on the GST impact to distributors. The company is also an active participant in industry-wide initiatives led by the General Insurance Council. These include expanding the common empanelment of hospitals with standardized rates (targeting 5,000 hospitals in 6-9 months) and implementing standard treatment protocols to reduce unnecessary admissions and control claims costs.

    05

    Financial Health and Solvency

    Niva Bupa maintains a strong balance sheet. The solvency ratio stood at a healthy 2.49. The company's Assets Under Management (AUM) reached approximately ₹9,000 crores, generating an annualized investment yield of 7.3% for the nine-month period. Management expressed confidence in its capital position, stating the solvency level is as per their plan and should improve in Q4, which is seasonally strong for IGAAP profits.

    06

    Product Traction and Customer Metrics

    The recently launched 'Reassure 3.0' product has become the company's fastest-growing product, favored for its unique features like inflation-proofing and comprehensive OPD coverage. On the customer front, the company reported an improvement in its blended Net Promoter Score (NPS) by 5 points to 58. The cashless NPS remains very strong at 67, and the claim settlement ratio is maintained at a best-in-class level of nearly 95%.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.